You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AIM Buy Disclosure
Equels Thomas K · SEC Form 4 · Filed Nov 12, 2026
Buy
Calculated transaction value
$5.38K
Equels Thomas K CEO & President
AIM
Transaction date
Nov 10, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed 2 days later
AIM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 39,000 shares @ $0.14
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-051199
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$5.38K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aim Immunotech Inc. AIM Current | Buy | Nov 10, 2026 | $5.38K |